Related by context. All words. (Click for frequent words.) 73 intravesical infusion therapy 72 humanized therapeutic 72 accumulate preferentially 71 5 HT2A serotonin 70 AAG geldanamycin analog 70 5 HT1A receptor 70 pralatrexate injection folate analogue 70 pan histone deacetylase 70 CYP#A# CYP#D# 69 Angiotensin Converting Enzyme 69 selective serotonin 2C receptor 69 RAS MAPK pathway 69 IMiDs ® compound 69 Crofelemer budesonide foam 69 Peginterferon alfa 2b 68 Pruvel TM 68 reformulates existing FDA 68 Zorbtive TM 68 IAP inhibitor 68 targeted antifolate 68 Mg Usa 68 IgG1 monoclonal antibody 68 5 HT2A inverse 68 potent topoisomerase II 68 receptor inhibiting monoclonal 68 IMiDs R 68 Kinesin Spindle Protein KSP 68 IMiDs ® 68 sapacitabine CYC# 68 folate analogue metabolic 68 peptidic compound 68 CYT# potent vascular disrupting 67 vapreotide acetate 67 triggers apoptosis programmed 67 GTC recombinant form 67 non porcine pancreatic 67 pharmacologically active isomer 67 Pertuzumab 67 GRNOPC1 contains 67 Antithrombin 67 Recombinant Human 67 selective A2A adenosine receptor 67 Soluble CD# 67 certain protein tyrosine 67 inflammatory PDE 67 R Saizen R 67 non nucleoside inhibitor 67 agonistic human 67 selective modulator 67 NS5b 67 memantine HCl 67 tenofovir disoproxil fumarate Viread 67 refractory chronic lymphocytic 67 HCV RNA polymerase 67 Granted Orphan Drug 67 Gamunex C 67 CD4 monoclonal antibody 67 small molecule glucokinase 67 chimeric monoclonal antibody 67 NS5B polymerase 66 inhibitor COX 66 Romiplostim 66 recurrent metastatic ovarian cancer 66 Rigel R# 66 sorafenib tablets small 66 Topoisomerase II 66 Mg Uk 66 reversible inhibitors 66 Dementia Related Psychosis 66 5 Fluorouracil 66 erlotinib Tarceva ® 66 Fast Track designations 66 Hormone Refractory Prostate Cancer 66 FUSILEV enhances 66 Anti Tumor 66 novel emulsion formulation 66 protein tyrosine phosphatase 1B 66 Belimumab 66 IMPDH inhibitor 66 targeted radiotherapeutic 66 agents Tabun Sarin 66 MAGE A3 ASCI 66 Xcellerated T Cells 66 raloxifene Evista 66 hypereosinophilic syndrome 66 Randomized Phase II 66 INSPIRE Trial Phase III 66 peptibody 66 Lubiprostone 66 receptor tyrosine kinase inhibitor 66 Trastuzumab DM1 66 liver resection surgeries 66 Alfacell proprietary ribonuclease 66 taxane derivative 66 TO AVOID PREGNANCY WHILE 66 OMP #R# 66 MSCRAMM ® 66 oral dihydropyrimidine dehydrogenase DPD 66 Survivin antagonist 66 topoisomerase II inhibitor 66 Panflu TM Sinovac 66 Hsp# Inhibitor 66 Telik logo TELINTRA 66 novel synthetic PEGylated 66 CDK cyclin dependent 66 cortisol synthesis 66 TRIOLEX HE# APOPTONE HE# 66 small molecule Hedgehog 66 IMiDs 66 Talabostat 66 attach auristatin 66 ADP receptor antagonist 66 PRN FDA Approves 65 liposomal formulation 65 DNA methyltransferase inhibitors 65 Ixabepilone 65 pathophysiological effects 65 Meets Primary Endpoint 65 TNF Tumor Necrosis Factor 65 Kuvan sapropterin dihydrochloride 65 brivanib 65 alpha 2A adrenergic 65 CYP#A# substrate 65 ZOLINZA 65 orally administered inhibitor 65 sorafenib tablets 65 alpha folate receptor 65 cutaneous T 65 XL# anticancer compounds 65 myelodysplastic myeloproliferative diseases 65 Initiates Enrollment 65 Azacitidine 65 Adjuvant Treatment 65 apoptosis proteins 65 Receives Orphan Drug Designation 65 ® bortezomib 65 mRNA antagonist 65 2A receptor agonist 65 kappa B 65 generation purine nucleoside 65 kidney urologic 65 Febuxostat 65 Granulocyte Colony Stimulating Factor 65 oncolytic virus therapies 65 Epidermal Growth Factor Receptor 65 samalizumab 65 Kahalalide F 65 chronic eosinophilic leukemia 65 vaccine ChronVac C 65 Hexvix ® 65 PEGylated anti 65 recombinant PSMA vaccine 65 Kinase Inhibitor 65 epoetin delta 65 Lenocta TM sodium stibogluconate 65 MKC# MT 65 Prolongs Survival 65 Teriflunomide 65 XOMA 3AB biodefense 65 Vitrasert R 65 Tarceva TM 65 R sorafenib tablets 65 Shows Promise Against 65 Panzem R 65 Aeolus Pharmaceuticals Announces 65 cyclin dependent kinase inhibitor 65 MKC# MKC# PP 64 MKC# 64 includes AstraZeneca Accolate 64 activin receptor type 64 Initiates Clinical 64 Demonstrates Potential 64 RhuDex R 64 dasatinib Sprycel ® 64 Pemetrexed 64 sodium glucose cotransporter 64 VEGFR2 inhibitor 64 transthyretin TTR 64 anionic backbone 64 Tyrosine Kinase Inhibitor 64 reversible inhibitor 64 sulfonylurea metformin 64 Taxol ® 64 hyaluronidase enzyme 64 Tumor Response 64 Epratuzumab 64 2 methoxyestradiol 64 dopamine D2 64 Voreloxin 64 docetaxel Taxotere R 64 insulin glulisine 64 adenosine A2A 64 Vidaza azacitidine 64 MCSP respectively 64 mineralocorticoid receptor 64 humanized interleukin 6 64 proteasome inhibitor 64 MTP inhibitor 64 developing Bicifadine serotonin 64 Pharmacokinetics PK 64 YONDELIS 64 Umbilical cord stem cells 64 GVAX ® 64 Phase 2b Clinical Trial 64 LymphoStat B belimumab 64 develop HBV reactivation 64 FDA Okays 64 alpha antagonist 64 MEK Inhibitor 64 Factor Receptor 64 ® lenalidomide 64 PEGylated Fab fragment 64 HDAC Inhibitor 64 virus HCV protease inhibitor 64 Aflibercept 64 Bayer HealthCare Onyx Pharmaceuticals 64 Antigen Specific 64 Vidofludimus 64 Panzem R NCD 64 nilotinib Tasigna 64 cathepsin K inhibitor 64 TELINTRA R 64 Evoltra ® 64 5 fluorouracil leucovorin 64 GTC recombinant human 64 class mGluR5 inhibitor 64 HIF 1α 64 TRAIL induced apoptosis 64 luteinizing hormone releasing 64 selectively inhibited 64 peripherally restricted 64 Cathepsin B 64 Pegloticase 64 5alpha reductase 64 PNP inhibitor 64 cyclin dependent kinase CDK 64 somatostatin analog 64 ATRA IV 64 selective phosphodiesterase 64 mTOR mammalian target 64 Lenalidomide 64 Sandimmune 64 thalidomide Thalomid 64 Lyophilized 64 Atripla combines 64 highly selective inhibitor 64 Methylnaltrexone 64 Grants Orphan Drug 64 HuCAL PLATINUM ® CysDisplay 64 Synta Announces 64 KSP inhibitor 64 Immunotherapeutic 64 oral nucleoside analogue 64 formerly LymphoStat B 64 poly ADP ribose polymerase 64 glycoprotein GP IIb IIIa 64 octreotide acetate 64 oral immunomodulatory 64 metaglidasen 64 Daclizumab 64 novel VDA molecule 64 Degarelix 64 5 HT6 receptor 64 PD LID 63 iloprost synthetic compound 63 EOquin TM phase 63 Pruvel ™ 63 Submits Biologics License Application 63 Fast Track Status 63 Copegus ® 63 Temsirolimus 63 HER2 HER2 63 microtubule inhibitor 63 Kinoid 63 vinorelbine tartrate 63 pharmacogenomic translational research 63 Orally administered 63 Successfully Completes Phase 63 Files IND 63 Therapeutic Efficacy 63 potent suppressor 63 Zevalin R Ibritumomab 63 fusion enhancers 63 Protein Kinase C 63 small molecule thrombopoietin 63 cetuximab Erbitux R 63 Initiates Phase II 63 Decitabine 63 using Inovio MedPulser 63 PDGFR B 63 mda 7 63 erlotinib Tarceva R 63 Tumor Necrosis Factor 63 PDE4 63 histone deacetylase inhibitor 63 cromolyn sodium 63 relapsed MM 63 Cutaneous T 63 brand ciclesonide HFA 63 Tumor necrosis factor 63 Simulect 63 factor Xa 63 Trandolapril 63 Bosutinib 63 STRIKE PRICE COMPARES TO 63 Completes Patient Enrollment 63 Vildagliptin 63 docetaxel Taxotere ® 63 NeuroSTAT ® 63 R bisoprolol Euthyrox 63 Imatinib mesylate 63 humanised monoclonal antibody 63 Gabriel Mollet 63 Announces Tentative Approval 63 Momenta Pharmaceuticals Announces 63 Upregulation 63 gemtuzumab ozogamicin 63 CysDisplay R 63 Elvitegravir 63 volociximab 63 CD# expressing 63 deacetylase 63 novel tubulin binding 63 Recurrent Glioblastoma 63 Liposomal 63 sunitinib Sutent ® 63 5 HT6 63 VANTAS ® 63 Cardium Therapeutics TM 63 Complicated Skin 63 Dasatinib 63 AKT inhibitor 63 huN# DM1 63 5 HT4 63 selectively binds 63 semi synthetic lipoglycopeptide 63 anti botulism antibody 63 HepDirect prodrug 63 cAMP dependent 63 Darinaparsin 63 alefacept 63 Aliskiren 63 pan HDAC inhibitor 63 R MSCRAMM 63 defensin mimetic antibiotic 63 polyglutamate 63 synthetic siRNA 63 inhibit oxidative stress 63 Dose Escalation 63 paclitaxel Taxol ® 63 Antibody Drug Conjugate 63 Posaconazole 63 AnaSpec Introduces 63 AFREZZA TM 63 Initiate Phase 63 acetonide FA 63 targeting CD# 63 including cyclosporine methotrexate 63 DP VPA 63 proprietary polysaccharide 63 thymidylate synthase TS 63 gemcitabine cisplatin 63 Orally Active 63 Vandetanib 63 ABLYNX 63 PDE4 inhibitor 63 polysaccharide polymer 63 Silodosin 63 hypoxia activated prodrug 63 Thiazolidinediones 63 Everolimus 63 peripherally acting 63 Aptamer 63 FDA APPROVES 63 PF # [002] 63 investigational humanized monoclonal antibody 63 Pazopanib 63 Bortezomib 63 Ocrelizumab 63 Peginterferon 63 glucocerebroside primarily 63 candidates Azedra TM 63 receptor partial agonist 63 enzymatically activated within 63 Potelligent TM Technology 63 nasal calcitonin product 63 microsomal triglyceride transfer 63 albiglutide 63 Estrogen Receptor 63 Veronate R 63 By JAMAAL ABDUL 63 oral proteasome inhibitor 63 aspartyl 63 5 lipoxygenase inhibitor 63 metastatic colorectal 63 bevacizumab Avastin R 63 Akt activation 63 syngeneic 63 Known hypersensitivity 63 LAB CGRP 62 pregabalin Lyrica 62 NMDA N 62 Valcyte tablets 62 Luteinizing Hormone Releasing Hormone 62 5 FU leucovorin 62 PSMA ADC 62 tenofovir Viread 62 cyclooxygenase COX 62 TRANSDUR ® 62 Oral Calcitonin 62 Serostim ® 62 Tyrima 62 Aurora Kinase 62 RON Notch 62 Antitumor Activity 62 c Raf kinase 62 carbohydrate polymer 62 Vidaza R 62 Initiates Phase III 62 Levels Linked 62 include Alferon N 62 CCR5 receptor antagonist 62 Glucagon Like Peptide 62 Ag Cu Pb 62 humanised antibody 62 Fludara ® 62 HuMax 62 Pralatrexate 62 cosmetic cosmeceutical products 62 Staphylococcus aureus Immune Globulin 62 Transition Therapeutics Announces 62 using VIAdel TM 62 TLR7 agonist 62 HER1 62 See CLINICAL PHARMACOLOGY 62 colony stimulating factor 62 potent antiproliferative 62 Etanercept 62 allogeneic epidermal 62 mitogen activated protein kinases 62 novel histone deacetylase 62 Inhaled nitric oxide 62 Interferon beta 62 Initiates Clinical Trial 62 Altera Nebulizer System 62 Vincristine 62 FDA Accepts 62 specific lectin receptors 62 IL# PE#QQR 62 tests miRview TM 62 beta 1a 62 covalently bound 62 5 FU cytotoxic 62 alfa 2a 62 interleukin IL -# 62 Valproic acid 62 platform HDL Mimetic 62 Janus kinase 62 transiently transfected 62 humanized anti 62 multi kinase inhibitor 62 Newly Diagnosed Multiple Myeloma 62 Hypoxia Inducible Factor 62 M1 muscarinic 62 opioid receptor antagonist 62 Denufosol 62 #HT# 62 camptothecin CPT 62 Kit CD# positive 62 Achieves Primary Endpoint 62 Cyclooxygenase 2 62 Rindopepimut 62 experimental autoimmune encephalomyelitis 62 radiolabeled TM# 62 ENMD # 62 Treatment Reduces 62 Plaque Psoriasis 62 autologous cellular immunotherapy 62 delta gamma agonist 62 Patients Treated With 62 metastatic malignant 62 Glucocorticoid 62 potent inducer 62 JAK2 Inhibitor 62 bone marrow lymph nodes 62 substantially excreted 62 tetracycline antibiotic 62 Multipotent 62 Monoclonal antibody 62 tumor xenograft models 62 MEK ERK 62 Bezielle 62 thrombopoietin TPO natural 62 humanised antibody designed 62 oral picoplatin 62 Orphan Drug status 62 Tubulin 62 methyl D aspartate 62 rheumatoid arthritis psoriatic arthritis 62 Sumatriptan Succinate 62 potently inhibit 62 p# MAP kinase 62 hepatoma 62 FSH follicle stimulating 62 aurora kinase 62 Glufosfamide 62 inverse agonist 62 Tetanus Toxoid Reduced Diphtheria 62 plasmid encoding 62 Pegylated 62 Investigational Oral 62 Vytorin combines 62 delta opioid receptor 62 TIMP 1 62 Novel Inhibitor 62 evaluating tivozanib 62 R pramlintide acetate 62 selective inverse agonist 62 HER2 ErbB2 62 DORIBAX 62 tubulin inhibitor 62 HCV Protease Inhibitor 62 essential thrombocythemia ET 62 Cytotoxic T 62 inhibits plasma kallikrein 62 aspirin clopidogrel 62 PEGylated interferon 62 NeoLipid R 62 Romidepsin 62 Ganciclovir 62 Anidulafungin 62 ispinesib SB # 62 histone deacetylase HDAC 62 collagen sponge seeded 62 5 HT3 antagonist 62 Mimetics 62 novel topoisomerase II 62 THE UNDERLYING FUTURE 62 nucleoside analog 62 SUTENT ® 62 y Ambiente SERNA Honduras 62 Secretase 62 injectable investigational 62 SPL# Gel vaginal microbicide 62 protein tyrosine phosphatases 62 Campath ® 62 Biogen Genentech 62 Sodium oxybate 62 III EGFRvIII 62 Peginterferon Alfa 2a 62 Carfilzomib 62 Hedgehog Pathway Inhibitor 62 anti angiogenic agent 62 Vascugel 62 Adenoviral 62 Monopril 62 CD# CEA 62 effector function 62 Critical Therapeutics Zyflo 62 oral ghrelin agonist 62 Camptosar ® 62 chemotherapeutic agents carboplatin 62 sunitinib Sutent 62 chronic idiopathic thrombocytopenic purpura 62 Progenitor Cells 62 secretory phospholipase A2 62 Zalypsis 62 RANK Ligand inhibitor 62 cyclophosphamide methotrexate 62 HIF 1a 62 Adenosine A2A 62 5 HT2A 62 DNA intercalator 61 nonnucleoside reverse transcriptase inhibitors 61 granted Ortec 61 Tasigna prolongs 61 papillary renal cell carcinoma 61 Inc. www.micromet inc.com 61 Presents Preclinical Data 61 dimebon latrepirdine 61 radiolabeled 61 Pathway Inhibitor 61 serine threonine 61 sorafenib Nexavar 61 K ras mutations 61 Drug Absorption 61 ARRY # 61 Omacetaxine 61 CD# monoclonal antibody 61 sulfonylhydrazine class 61 PI3K Akt 61 azilsartan medoxomil 61 HMG CoA reductase inhibitors 61 COLAZAL R 61 enhance ApoA 61 serotonin norepinephrine reuptake inhibitor 61 Undesirable alterations 61 selective kinase inhibitor 61 Bafetinib 61 potently inhibits 61 Submits NDA 61 statin HMG CoA reductase 61 topical antifungal product 61 topical gel formulation 61 Tibotec Therapeutics division 61 Pivotal Phase III 61 Inhalation Powder 61 mTOR inhibitor 61 Ispinesib SB # 61 triggers apoptosis 61 AVI BioPharma Announces 61 lenalidomide Revlimid R 61 Lambert Eaton Myasthenic 61 biologic DMARD 61 Daptomycin 61 Maribavir 61 highly selective endothelin 61 mertansine 61 DG# compounds targeting 61 retinoic acid receptor 61 deoxy 61 orally inhaled 61 8mg/kg 61 number NCT# ClinicalTrials.gov 61 ISTODAX 61 EGFR TKI 61 Vidaza ® 61 epoetin zeta 61 Thiarabine 61 T#I [002] 61 long acting muscarinic 61 Golimumab 61 methylnaltrexone bromide 61 Node Positive 61 Albuferon albinterferon alfa 2b 61 Firdapse TM amifampridine phosphate 61 BCG refractory carcinoma 61 cisplatin resistant 61 oral prodrug 61 mitoxantrone plus 61 Smooth Muscle 61 Bone Morphogenetic Protein 61 SYN# 61 via intradermal injections 61 diagnostic molecular imaging 61 Psoriasis Drug 61 abnormal hematopoietic cells 61 Protease Inhibitor 61 Demonstrate Significant 61 Drug Candidate 61 iobenguane 61 Receives Approvable Letter 61 lactate dehydrogenase LDH 61 triiodothyronine T3 61 drotrecogin alfa activated 61 novel oral anticoagulant 61 Endologix Powerlink System 61 prostanoid 61 Sudhir Agrawal D.Phil 61 Lispro 61 Drug Shows Promise 61 antidepressants fluoxetine 61 myelofibrosis polycythemia vera 61 Phase III multicenter 61 Receptor Antagonists 61 Personalized Immunotherapy 61 blinded randomized placebo controlled 61 sapropterin dihydrochloride Phase 61 topically applied SEPA 61 hip osteonecrosis avascular 61 selective estrogen receptor modulator 61 cystic fibrosis transmembrane 61 Leukemias 61 Receives Orphan Drug 61 Antitumor 61 Dabigatran etexilate 61 cilengitide 61 AFREZZA ™ 61 factor TNF receptor 61 5 lipoxygenase 61 NK1 61 ixabepilone 61 recombinant interferon 61 Stromal 61 methyl CpG binding 61 Signaling Pathway 61 Annamycin 61 Poly ICLC 61 novel topoisomerase 61 Cariprazine 61 3TC lamivudine 61 Merck OSI Pharmaceuticals 61 Proc Am Soc 61 Begins Dosing 61 MUSE ® 61 motexafin gadolinium Injection 61 Pruvel ™ prulifloxacin 61 Fluorouracil 61 GLPG# 61 Enhanze Technology 61 CorVue ™ 61 ACTEMRA TM 61 Peroxisome Proliferator Activated Receptor 61 azelastine hydrochloride 61 deCODE AF TM 61 non thiazolidinedione TZD 61 Pharma Merck Serono 61 androgen receptor AR 61 potent triglyceride lowering 61 PrevOnco 61 Malignant Glioma 61 injected subcutaneously 61 psoriasis rheumatoid arthritis 61 Traficet EN 61 B lymphocyte stimulator 61 Tumour Vascular Disrupting Agent 61 topical non steroidal 61 estramustine 61 Delta opioid receptor 61 GW# [003] 61 fosbretabulin 61 trastuzumab Herceptin R 61 ACE Inhibitors 61 Zidovudine Tablets 61 small molecule chemotherapeutic 61 soluble tumor necrosis 61 BEXXAR Therapeutic Regimen 61 Pirfenidone 61 LHRH receptor positive 61 SensoLyte ® 61 Long acting beta2 61 Archexin 61 Enzastaurin 61 CD# CD# 61 Piperacillin 61 Pharmacokinetic Study 61 High Dose quadruples 61 MGd 61 IG HCR ;) CO 61 Clevudine 61 Forodesine 61 IgG1 61 Oral NKTR 61 Interferon beta 1b 61 PDE# 61 #I TM# 61 selective antagonist 61 Antiangiogenic 61 cisplatin gemcitabine 61 FOLOTYN ® 61 Receptor Agonist 61 biologic antibody 61 CYT# QbG# 61 endogenous ligands 61 Novel Oral 61 ospemifene 61 Biomerix Corporation 61 monocyte chemotactic protein 61 Anti Tumor Activity 61 phosphatidylinositol 3 61 orally disintegrating 61 Improves Outcomes 61 Irinotecan 61 glucagon receptor 61 imatinib Gleevec ® 61 Amrubicin 61 demonstrated antitumor activity 61 sufficient quantities Phe 61 Multi Lineage Progenitor 61 Epothilones 61 Aad Schalke Dutch 61 Trobalt 61 Safinamide 61 urate oxidase 61 potently inhibited 61 acyclovir Lauriad R 61 TORISEL TM 61 Anthracycline 61 leukemia multiple myeloma 61 Ziprasidone 61 lintuzumab SGN 61 hypoxia inducible factor 61 Prodarsan R 61 Arimoclomol 61 5 HT2C 60 #beta HSD 1 60 THR beta agonist 60 capsules USP 60 HuMax TAC 60 constitutively expressed 60 budesonide pMDI 60 Gemzar gemcitabine 60 ribonucleotide reductase clinically validated 60 Capesaris 60 nicotinamide adenine dinucleotide 60 Small Molecule 60 COLAZAL ® 60 GSK# [001] 60 evaluating satraplatin 60 receptor blocker 60 Imetelstat 60 Therapeutic Competitors Companies 60 weekly subcutaneous injections 60 Cytochrome P# 60 Kosan proprietary 60 Receives Fast Track 60 gonadotropin releasing hormone GnRH 60 Syndrome LEMS 60 Vascular Disrupting Agent 60 developing Zerenex ferric 60 lamivudine 3TC 60 TNF alpha selectively neutralizing 60 ritonavir boosted 60 Castration Resistant Prostate Cancer 60 subcutaneous formulation 60 MT#/MEDI-# 60 human antithrombin 60 telomerase therapeutic 60 Files Investigational 60 purified inactivated vaccine 60 Relapsed Refractory Multiple Myeloma 60 HGS ETR2 60 Novel Therapeutic 60 vitamin B# folic acid 60 CEL SCI Phase III 60 Soft Tissue Sarcoma 60 antibody MT# 60 gastrin analogue TT 60 Reclast zoledronic acid 60 Warfarin Coumadin 60 RhuDex ® 60 PEG SN# 60 Oracea TM 60 matrix metalloprotease 60 XL# XL# 60 Bone Metastases 60 antibody trastuzumab 60 hA# 60 VISICOL R 60 MT# MEDI 60 diarrhea predominant irritable 60 Transfersome ® 60 histone deacetylase HDAC inhibitor 60 Am J Clin 60 Bucindolol 60 Erythropoiesis stimulating agents 60 Liprotamase 60 HCD# [002] 60 selectin antagonist 60 HIV treatments Reyataz 60 treat male hypogonadism 60 IONSYS TM 60 noninvasive outpatient 60 #mg #mg #mg [003] 60 LEUKINE 60 Prostacyclin 60 novel cardiac myosin 60 DGAT 60 Small Modular SMIP 60 OctoPlus licensed 60 BLP# Liposome Vaccine 60 JAK#/JAK# inhibitor CYT# 60 SuperAntibody 60 sphingosine 1 60 Aclidinium bromide 60 S#P# 60 HER pathway 60 dependent cellular cytotoxicity 60 Arno Therapeutics 60 HCV polymerase 60 SAR# [002] 60 Submits Supplemental 60 antiapoptotic 60 DEB# 60 intratumoral injection 60 alpha#beta# 60 recombinant soluble 60 selective agonist 60 Certolizumab pegol 60 M# rationally 60 cyclic AMP cAMP 60 Enterobacter spp 60 aliskiren amlodipine 60 R roscovitine 60 Initiate Clinical Trial 60 Plicera 60 TKB# 60 Improves Survival 60 Gleevec resistant 60 CD# molecule 60 Forodesine HCl 60 pegylated 60 Herceptin trastuzumab 60 siRNA binds 60 receptor inhibitor 60 tumor vascular disrupting 60 rapamycin kinase 60 busulfan 60 4SC AG ISIN DE# 60 Saxagliptin 60 gefitinib Iressa 60 subcutaneously administered 60 inhalations twice 60 AVASTIN 60 selectively inhibit 60 adjuvant GIST 60 doxorubicin cyclophosphamide 60 pancreatic enzyme replacement 60 CDK5 60 VEGF induced 60 CYTEC INDUSTRIES 60 Leuprolide 60 Aplidin R 60 thromboxane A2 60 Tenormin 60 orally dosed 60 NB S# strontium malonate 60 Shows Promising 60 receptor modulators 60 Pafuramidine 60 Oral Formulation 60 glucokinase 60 Atrasentan 60 SPRYCEL ® 60 CD# + [001] 60 developed preclinically 60 Plaquenil 60 Demonstrates Significant 60 Fc fusion protein 60 Brimonidine 60 ALVESCO R 60 Platinol ® cisplatin 60 Clinical Trial Evaluating 60 waehrend der Boerse 60 REVIVE Diabetes 60 Aloprim TM allopurinol sodium 60 Novel Antibiotic 60 1α 60 PKC# 60 alpha#beta# integrin 60 Medullary Thyroid Cancer 60 selectively silencing 60 Phase 2a Clinical Trial 60 XOMA 3AB 60 herpetic keratitis 60 Xcytrin R 60 Tanespimycin 60 Fluconazole 60 Prostate Cancer Vaccine 60 Long Term Efficacy 60 CYC# 60 Levoleucovorin 60 Targretin capsules 60 Cyclophosphamide 60 R vitespen 60 INTEGRILIN R eptifibatide Injection 60 personalized cellular immunotherapy 60 Angiotensin 60 TRACON Pharmaceuticals 60 Pancuronium bromide 60 Ostarine ™ 60 Darunavir 60 alkylated amino acid 60 Tyrosine Kinase Inhibitors 60 tazobactam 60 Preclinical studies suggest 60 PROCRIT ® 60 calcineurin inhibitor 60 Sevelamer 60 mTOR kinase 60 M2 subunit 60 amprenavir 60 Sphingosine 1 60 basiliximab 60 delivers fluocinolone acetonide FA 60 TRO# 60 Receptor Antagonist 60 PI3K/Akt pathway inhibitor 60 induced phosphorylation 60 MOVIPREP R 60 Levaquin levofloxacin 60 FS Antihemophilic Factor Recombinant 60 Locked Nucleic Acid LNA 60 Talotrexin 60 XIAFLEX ™ 60 #HT#A 60 antiangiogenic agent 60 NOXAFIL Oral Suspension 60 hENT1 60 guanylate cyclase C 60 BUPHENYL R 60 Accelerated Partial Breast Irradiation 60 Metformin GR 60 please visit http:/www.avastin.com 60 alkylating 60 golimumab CNTO 60 ONCASPAR 60 BEZ# 60 aerosolized AAT